Staar Surgical (STAA) EBIT (2010 - 2026)

Staar Surgical's EBIT history runs 17 years deep, the most recent figure standing at $8.0 million for Q2 2026.

• Quarterly EBIT rose 113.9% year-over-year to $8.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$26.3 million (up 61.12% YoY) and the FY2026 annual result came in at -$91.7 million, down 627.25% from the prior year.
• EBIT was $8.0 million for Q2 2026 at Staar Surgical, up from -$22.8 million in the prior quarter.
• Across five years, EBIT topped out at $18.5 million in Q3 2025 and bottomed at -$57.4 million in Q1 2025.
• A 5-year average of -$1.4 million and a median of $6.3 million in 2023 frame the typical range for EBIT.
• Annual changes were most pronounced in 2023 — EBIT soared 979.36% — and 2025, when it tumbled 2416.48%.
• Staar Surgical's EBIT stood at $964000.0 in 2022, then surged by 979.36% to $10.4 million in 2023, then plunged by 368.24% to -$27.9 million in 2024, then jumped by 166.25% to $18.5 million in 2025, then sank by 56.85% to $8.0 million in 2026.
• Business Quant data shows STAA's EBIT at $8.0 million in Q2 2026, -$22.8 million in Q1 2026, and $18.5 million in Q3 2025.